Antisense inhibition of surfactant protein A decreases tubular myelin formation in human fetal lung in vitro

Am J Physiol Lung Cell Mol Physiol. 2002 Mar;282(3):L386-93. doi: 10.1152/ajplung.00410.2000.

Abstract

Surfactant protein A (SP-A) is the most abundant of the surfactant-associated proteins. SP-A is involved in the formation of tubular myelin, the modulation of the surface tension-reducing properties of surfactant phospholipids, the metabolism of surfactant phospholipids, and local pulmonary host defense. We hypothesized that elimination of SP-A would alter the regulation of SP-B gene expression and the formation of tubular myelin. Midtrimester human fetal lung explants were cultured for 3-5 days in the presence or absence of an antisense 18-mer phosphorothioate oligonucleotide (ON) complementary to SP-A mRNA. After 3 days in culture, SP-A mRNA was undetectable in antisense ON-treated explants. After 5 days in culture, levels of SP-A protein were also decreased by antisense treatment. SP-B mRNA levels were not affected by the antisense SP-A ON treatment. However, there was decreased tubular myelin formation in the antisense SP-A ON-treated tissue. We conclude that selective elimination of SP-A mRNA and protein results in a decrease in tubular myelin formation in human fetal lung without affecting SP-B mRNA. We speculate that SP-A is critical to the formation of tubular myelin during human lung development and that the regulation of SP-B gene expression is independent of SP-A gene expression.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cation Exchange Resins / pharmacology
  • Embryonic and Fetal Development / drug effects
  • Fetus / metabolism
  • Homeostasis
  • Humans
  • Immunohistochemistry
  • In Vitro Techniques
  • L-Lactate Dehydrogenase / metabolism
  • Lipids / pharmacology
  • Lung / embryology*
  • Myelin Sheath / metabolism*
  • Oligonucleotides, Antisense / pharmacology*
  • Proteolipids / antagonists & inhibitors*
  • Proteolipids / genetics
  • Proteolipids / metabolism
  • Pulmonary Surfactant-Associated Protein A
  • Pulmonary Surfactant-Associated Proteins
  • Pulmonary Surfactants / antagonists & inhibitors*
  • Pulmonary Surfactants / genetics
  • Pulmonary Surfactants / metabolism
  • RNA, Messenger / metabolism

Substances

  • Cation Exchange Resins
  • Lipids
  • Lipofectamine
  • Oligonucleotides, Antisense
  • Proteolipids
  • Pulmonary Surfactant-Associated Protein A
  • Pulmonary Surfactant-Associated Proteins
  • Pulmonary Surfactants
  • RNA, Messenger
  • L-Lactate Dehydrogenase